Specify a stock or a cryptocurrency in the search bar to get a summary
Bloomage Biotechnology Corp Ltd
688363Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is headquartered in Jinan, the People's Republic of China. Address: Tech Development Zone, Jinan, China, 250101
Analytics
WallStreet Target Price
408.35 CNYP/E ratio
71.2418Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 688363
Dividend Analytics 688363
Dividend growth over 5 years
–Continuous growth
3 yearsPayout Ratio 5 years average
32 %Dividend History 688363
Stock Valuation 688363
Financials 688363
Results | 2019 | Dynamics |